Cargando…
Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667428/ https://www.ncbi.nlm.nih.gov/pubmed/33224359 http://dx.doi.org/10.5114/aoms.2019.89217 |
_version_ | 1783610311539949568 |
---|---|
author | Nicoś, Marcin Wojas-Krawczyk, Kamila Krawczyk, Paweł Chmielewska, Izabela Wojcik-Superczyńska, Magdalena Reszka, Katarzyna Kieszko, Robert Góra-Florek, Anna Dudek, Małgorzata Świniuch, Daria Papiewski, Wojciech Całka, Paulina Ciesielka, Marzanna Ramlau, Rodryg Milanowski, Janusz |
author_facet | Nicoś, Marcin Wojas-Krawczyk, Kamila Krawczyk, Paweł Chmielewska, Izabela Wojcik-Superczyńska, Magdalena Reszka, Katarzyna Kieszko, Robert Góra-Florek, Anna Dudek, Małgorzata Świniuch, Daria Papiewski, Wojciech Całka, Paulina Ciesielka, Marzanna Ramlau, Rodryg Milanowski, Janusz |
author_sort | Nicoś, Marcin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7667428 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-76674282020-11-20 Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma Nicoś, Marcin Wojas-Krawczyk, Kamila Krawczyk, Paweł Chmielewska, Izabela Wojcik-Superczyńska, Magdalena Reszka, Katarzyna Kieszko, Robert Góra-Florek, Anna Dudek, Małgorzata Świniuch, Daria Papiewski, Wojciech Całka, Paulina Ciesielka, Marzanna Ramlau, Rodryg Milanowski, Janusz Arch Med Sci Letter to the Editor Termedia Publishing House 2019-11-03 /pmc/articles/PMC7667428/ /pubmed/33224359 http://dx.doi.org/10.5114/aoms.2019.89217 Text en Copyright: © 2019 Termedia & Banach http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Letter to the Editor Nicoś, Marcin Wojas-Krawczyk, Kamila Krawczyk, Paweł Chmielewska, Izabela Wojcik-Superczyńska, Magdalena Reszka, Katarzyna Kieszko, Robert Góra-Florek, Anna Dudek, Małgorzata Świniuch, Daria Papiewski, Wojciech Całka, Paulina Ciesielka, Marzanna Ramlau, Rodryg Milanowski, Janusz Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma |
title | Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma |
title_full | Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma |
title_fullStr | Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma |
title_full_unstemmed | Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma |
title_short | Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma |
title_sort | assessment of egfr gene mutations in circulating free dna in monitoring of response to egfr tyrosine kinase inhibitors in patients with lung adenocarcinoma |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667428/ https://www.ncbi.nlm.nih.gov/pubmed/33224359 http://dx.doi.org/10.5114/aoms.2019.89217 |
work_keys_str_mv | AT nicosmarcin assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma AT wojaskrawczykkamila assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma AT krawczykpaweł assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma AT chmielewskaizabela assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma AT wojciksuperczynskamagdalena assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma AT reszkakatarzyna assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma AT kieszkorobert assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma AT goraflorekanna assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma AT dudekmałgorzata assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma AT swiniuchdaria assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma AT papiewskiwojciech assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma AT całkapaulina assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma AT ciesielkamarzanna assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma AT ramlaurodryg assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma AT milanowskijanusz assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma |